Beta-lactamases in clinical isolates. Spectrum implications of sulbactam/ampicillin.
about
Beta-lactamase production in members of the family Enterobacteriaceae and resistance to beta-lactam-enzyme inhibitor combinations.Piperacillin, tazobactam, and gentamicin alone or combined in an endocarditis model of infection by a TEM-3-producing strain of Klebsiella pneumoniae or its susceptible variant.
P2860
Beta-lactamases in clinical isolates. Spectrum implications of sulbactam/ampicillin.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Beta-lactamases in clinical isolates. Spectrum implications of sulbactam/ampicillin.
@en
Beta-lactamases in clinical isolates. Spectrum implications of sulbactam/ampicillin.
@nl
type
label
Beta-lactamases in clinical isolates. Spectrum implications of sulbactam/ampicillin.
@en
Beta-lactamases in clinical isolates. Spectrum implications of sulbactam/ampicillin.
@nl
prefLabel
Beta-lactamases in clinical isolates. Spectrum implications of sulbactam/ampicillin.
@en
Beta-lactamases in clinical isolates. Spectrum implications of sulbactam/ampicillin.
@nl
P2093
P1433
P1476
Beta-lactamases in clinical isolates. Spectrum implications of sulbactam/ampicillin.
@en
P2093
P478
35 Suppl 7
P577
1988-01-01T00:00:00Z